Centenial Surgical Suture Ltd

Centenial Surgic's historical performance shows fluctuating net sales, increasing from 51.19 Cr in Mar'24 to 53.52 Cr in Mar'25, but it reported a loss with a profit after tax of -1.46 Cr in Mar'25, despite improved operating efficiency and cash flow from operations. Total liabilities and assets rose to 84.55 Cr in Mar'25, indicating financial challenges.

On 21-Nov, Centenial Surgical Suture Ltd witnessed a significant share price decline, closing at ₹96.00 with a drop of 5.23%. This downward movement reflects a combination of weak financial performance, deteriorating profitability metrics, and underwhelming market returns compared to benchmarks.

Centenial Surgic has experienced mixed historical performance, with net sales increasing from 36.93 Cr in Mar'21 to 53.52 Cr in Mar'25, despite a dip in Mar'23. However, profitability has declined, resulting in a negative profit before tax of -1.62 Cr and profit after tax of -1.46 Cr in Mar'25.

Centenial Surgic has shown mixed historical performance, with net sales rising to 53.52 Cr in Mar'25 but reporting a profit before tax of -1.62 Cr, indicating profitability challenges despite increased revenue and improved cash flow from operations. Total assets and liabilities both grew to 84.55 Cr, reflecting rising debt levels.

Centenial Surgic's historical performance shows fluctuating net sales, with a recent increase to 53.52 Cr in Mar'25, but profitability declined significantly, resulting in a profit after tax of -1.46 Cr. Despite improved cash flow from operations, the company faced challenges with rising expenditures and total liabilities.

As of 11-Nov, Centenial Surgical Suture Ltd's stock price is at 108.95, up 14.81% today, but it has declined 21.05% year-to-date and 17.46% over the past year. Despite short-term gains, the company faces significant long-term challenges, including a drastic profit drop and weak fundamentals.

As of 10-Nov, Centenial Surgical Suture Ltd is priced at 95.00, down 6.86%, and has underperformed its sector by 5.28%. The stock shows a bearish trend, trading below all key moving averages, with significant volatility and a year-to-date return of -31.16% compared to a positive 6.91% for the Sensex.

Centenial Surgic will announce its results on 13 November 2025.

As of 07-Nov, Centenial Surgical Suture Ltd's stock price is Rs 102.00, up 5.05% after a trend reversal. Despite today's gains, the stock has underperformed over the past year and week compared to the Sensex, with a significant decline of 26.09% year-to-date.

As of 06-Nov, Centenial Surgical Suture Ltd's stock price is Rs 95.00, down 7.14% and underperforming its sector. The stock has declined 12.04% over the past week and 31.16% year-to-date, contrasting sharply with the Sensex's performance.

As of 27-Oct, Centenial Surgical Suture Ltd's stock price is at 105.00, down 1.73%, and has underperformed its sector. Despite a 9.09% increase over the past week, it has a year-to-date decline of 23.91%, indicating poor long-term performance and lack of investor confidence.

As of 17-Oct, Centenial Surgical Suture Ltd's stock price is Rs 97.85, down 4.07%, reflecting a total decline of 8.38% over the last two days. The stock has consistently underperformed against the Sensex, with significant drops in both price and investor participation.

As of 15-Oct, Centenial Surgical Suture Ltd's stock price is at 108.90, reflecting an 8.57% increase. Despite recent gains, investor participation has declined, and the stock remains below long-term moving averages, indicating potential challenges ahead.

As of 10-Oct, Centenial Surgical Suture Ltd's stock price is at 100.50, down 6.94%, and has significantly underperformed its sector and the broader market. The stock is in a bearish trend, trading below all key moving averages, with a notable decline in delivery volume, indicating weak investor sentiment.